News, views and contacts from the global Pharmaceutical industry

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

August 2016

Top

FDA approves new drug that 'melts away blood cancer' for use in patients 23 August 2016 The US Food and Drug Administration (FDA) has granted approval to a potent anti-cancer treatment, venetoclax, which successfully trialled in Melbourne,...

Lilly and AstraZeneca receive FDA fast track designation for Alzheimer's drug 23 August 2016 Eli Lilly and AstraZeneca have received fast track designation from the US Food and Drug Administration (FDA) for AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor for...

Gilead’s Truvada for HIV-1 infection receives EC marketing approval 23 August 2016 The European Commission (EC) has granted marketing authorisation for US-based Gilead Sciences’ once-daily Truvada to reduce the risk of sexually acquired HIV-1...

Genekam develops therapeutic molecule candidate against Zika viruses 22 August 2016 German-based company Genekam Biotechnology has developed the first potential therapeutic molecule candidate against Zika...

India develops world’s first leprosy vaccine 22 August 2016 India has developed the world’s first leprosy vaccine, which is soon to be planned for trials within five districts of Bihar and Gujarat...

Pfizer close to acquiring Medivation for approximately $14bn 22 August 2016 Drug giant Pfizer is close to signing a $14bn agreement to acquire biotech firm...

Teva Pharmaceutical secures marketing approval for CINQAERO from European Commission 19 August 2016 Teva Pharmaceutical has secured marketing authorisation for CINQAERO (reslizumab) from the European...

Deals this week: Omeros Corporation, Cytocentrics, Recro Pharma 19 August 2016 Bio-pharmaceutical company, Omeros Corporation, has announced the pricing for public offering of 3,478,260 shares of its common stock to be $11.5 per...

M&As this week: Mallinckrodt, Scintilla Pharmaceuticals, Lonza Group 19 August 2016 Mallinckrodt plc has announced plans to acquire Stratatech Corporation, a regenerative medicine company that develops proprietary skin substitute...

Mayne Pharma acquires Foam Assets from GSK for $50.1m 19 August 2016 Mayne Pharma has acquired on-market dermatology portfolio Foam Assets from GSK for $50.1m....

Report: Turkish pharmaceutical industry to reach $5.53bn in value by 2020 19 August 2016 Turkey’s pharmaceutical industry is set to grow from $5bn in 2015 to $5.53bn by 2020, at a compound annual growth rate of 2%, according to a new report from...

US court overturns Johnson & Johnson's patent claims for Remicade 18 August 2016 Johnson & Johnson (J&J) has announced that the District of Massachusetts Federal Court has overturned its patent claims for Remicade...

Canadian scientists develop nanorobotic agents to target cancerous tumours 18 August 2016 Researchers from Canada have developed new nanorobotic agents with the ability to navigate through the bloodstream to administer a drug with precision by specifically targeting active...

UK’s NICE disapproves Janssen’s Imbruvica for relapsed or refractory mantle cell lymphoma 18 August 2016 UK drugs cost watchdog National Institute for Health and Care Excellence (NICE) has noted in its draft appraisal consultation document (ACD) that it does not recommend ibrutinib to treat...

Aldevron completes production of Malaria DNA vaccine for US NMRC 17 August 2016 US biomedical manufacturer Aldevron has completed the production and delivery of a DNA-based vaccine to combat malaria for the Naval Medical Research Center...

FDA grants breakthrough therapy designation to anti-depressant medication Esketamine 17 August 2016 Johnson & Johnson subsidiary Janssen Research & Development’s investigational anti-depressant medication, Esketamine, has received Breakthrough Therapy Designation from the US Food and...

Einstein-Montefiore and CUNY receive NIH grant for HIV / AIDS care in Central Africa 17 August 2016 The US National Institutes of Health (NIH) has awarded a $9.4m grant to Albert Einstein College of Medicine and Montefiore and the City University of New York (CUNY) research team to lead the...

Sorrento subsidiary Scintilla acquires pain specialist Semnur for $200m 16 August 2016 US-based Sorrento Therapeutics’ subsidiary Scintilla Pharmaceuticals has entered into a binding term sheet to acquire pain specialist Semnur Pharmaceuticals for...

First dengue immunisation public programme in Americas begins 16 August 2016 Sanofi has announced that a large-scale public programme to immunise 500,000 individuals with Dengvaxia dengue vaccine has been launched in the...

AstraZeneca completes global licence agreement to tralokinumab for skin diseases 16 August 2016 British drugmaker AstraZeneca has completed an agreement for the global licence to tralokinumab in skin diseases with dermatology care specialist LEO Pharma....

Novartis executives in South Korea face allegations of illegal rebates 15 August 2016 Seoul Western District Prosecutors' Office has charged Swiss pharmaceutical company Novartis executives in South Korea for offering illegal rebates to...